Fragmentomic analysis of circulating tumor DNA-targeted cancer panelsKyle T. Helzer, Shuang G. Zhao, Marina N. Sharifi et al.|Annals of Oncology|2023Cited by 70
Longitudinal Molecular Profiling of Circulating Tumor Cells in Metastatic Renal Cell CarcinomaMatthew L. Bootsma, Shuang G. Zhao, Rana R. McKay et al.|Journal of Clinical Oncology|2022Cited by 28
High-Purity CTC RNA Sequencing Identifies Prostate Cancer Lineage Phenotypes Prognostic for Clinical OutcomesMarina N. Sharifi, Joshua M. Lang, Jamie M. Sperger et al.|Cancer Discovery|2025Cited by 16
Analysis of cfDNA fragmentomics metrics and commercial targeted sequencing panelsKyle T. Helzer, Shuang G. Zhao, Jennifer L. Schehr et al.|Nature Communications|2025Cited by 9
Abstract B016: Liquid biopsy biomarker analysis of a phase II trial of sacituzumab govitecan in castrate resistant metastatic prostate cancerJamie M. Sperger, Joshua M. Lang, Amy K. Taylor et al.|Cancer Research|2023Cited by 4